Immunohistochemical Expression of Programmed Death Ligand 1 in Oral Extranodal Diffuse Large B Cell Lymphoma

Objective  Lymphomas are the third most common cancer after squamous cell carcinoma and salivary gland tumors. Extranodal diffuse B cell lymphoma (DBCL) represents 30 to 58% of non-Hodgkin's lymphoma. One of the major problems of DBCL is the high likelihood of disease relapse following treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Said, Rania Hanafi Mahmoud, Hussein, Fatma F., El-Deeb, Amal M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329535/
https://www.ncbi.nlm.nih.gov/pubmed/35944575
http://dx.doi.org/10.1055/s-0042-1747951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329535/
https://www.ncbi.nlm.nih.gov/pubmed/35944575
http://dx.doi.org/10.1055/s-0042-1747951

Ejemplares similares